Life Expectancy in Pleural and Peritoneal Mesothelioma
Open Access
- 23 January 2017
- journal article
- research article
- Published by Hindawi Limited in Lung Cancer International
- Vol. 2017, 1-8
- https://doi.org/10.1155/2017/2782590
Abstract
Background. Mesothelioma is a rare cancer with a historically dire prognosis. We sought to calculate life expectancies for patients with pleural or peritoneal mesothelioma, both at time of diagnosis and several years later, and to examine whether survival has improved in recent years. Methods. Data on 10,258 pleural and 1,229 peritoneal patients from the SEER US national cancer database, 1973–2011, were analyzed using the Cox proportional hazards regression model. Results. The major factors related to survival were age, sex, stage, grade, histology, and treatment. Survival improved only modestly over the study period: 0.5% per year for pleural and 2% for peritoneal. Conclusions. Life expectancies were markedly reduced from normal, even amongst 5-year survivors with the most favorable characteristics and treatment options.Keywords
This publication has 25 references indexed in Scilit:
- An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesotheliomaCancer Treatment Reviews, 2013
- Malignant Pleural Mesothelioma: A Population-Based Study of SurvivalJournal of Thoracic Oncology, 2010
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Survival of peritoneal malignant mesothelioma in Italy: A population‐based studyInternational Journal of Cancer, 2008
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialThe Lancet, 2008
- Pathology of mesotheliomaEnvironmental Health and Preventive Medicine, 2008
- Malignant Mesothelioma and Occupational Exposure to Asbestos: A Clinicopathological Correlation of 1445 CasesUltrastructural Pathology, 2002
- Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systemsThorax, 2000
- The epidemiology of mesothelioma in historical contextEuropean Respiratory Journal, 1996
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976